Literature DB >> 14726762

Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells.

Françoise Cottrez1, Hervé Groux.   

Abstract

The regulation of immune responses to self-antigens is a complex process that involves maintaining self-tolerance while retaining the capacity to mount robust immune responses against invading microorganisms. Over the past few years, many new insights into this process have been gained, leading to the reemergence of the idea that regulatory T cells (Treg) are key players in immune regulation. These insights have raised fundamental questions concerning the definition of a Treg and what exactly constitutes T-cell-mediated suppression, identification of the signals and the cellular environment that promote the development and differentiation of these cells, and which signals maintain the homeostasis of the immune system. Thus far, the different models where Treg have been characterized cannot fully account for CD(4+)CD(25+) T cells. In this article, the authors propose the coexistence of two specialized types of CD(4+) Treg-innate and acquired-that differ in terms of their development, specificity, mechanisms, and sites of action.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726762     DOI: 10.1097/01.TP.0000106471.23410.32

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  20 in total

1.  Semen activates the female immune response during early pregnancy in mice.

Authors:  Martina Johansson; John J Bromfield; Melinda J Jasper; Sarah A Robertson
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

Review 2.  Tregs and transplantation tolerance.

Authors:  Patrick T Walsh; Devon K Taylor; Laurence A Turka
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

3.  Efficacy of telbivudine in the treatment of chronic hepatitis b and liver cirrhosis and its effect on immunological responses.

Authors:  Nan Meng; Xiao Gao; Wei Yan; Mi Wang; Ping Liu; Xiao-Dan Lu; Shu-Juan Zhang; Ya-Qi Lu; Wang-Xian Tang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

4.  Innate profiles of cytokines implicated on oral tolerance correlate with low- or high-suppression of humoral response.

Authors:  Maria F Silva; Alice O Kamphorst; Elize A Hayashi; Maria Bellio; Claudia R Carvalho; Ana M C Faria; Kátia C C Sabino; Marsen G P Coelho; Alberto Nobrega; Daniel Tavares; Antonio C Silva
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

5.  Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration.

Authors:  Susanne Hultkrantz; Sofia Ostman; Esbjörn Telemo
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

Review 6.  Function of tumor necrosis factor receptor family members on regulatory T-cells.

Authors:  Robert H Arch
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells.

Authors:  Hideaki Suzuki; Shinichi Sekine; Kosuke Kataoka; David W Pascual; Massimo Maddaloni; Ryoki Kobayashi; Keiko Fujihashi; Haruo Kozono; Jerry R McGhee; Kohtaro Fujihashi
Journal:  Gastroenterology       Date:  2008-05-15       Impact factor: 22.682

8.  Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.

Authors:  Diana Milojevic; Khoa D Nguyen; Diane Wara; Elizabeth D Mellins
Journal:  Pediatr Rheumatol Online J       Date:  2008-12-01       Impact factor: 3.054

9.  Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models.

Authors:  Jin Yu; Susanne Heck; Karina Yazdanbakhsh
Journal:  Am J Hematol       Date:  2007-08       Impact factor: 10.047

Review 10.  Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus?

Authors:  Henry Yim Wu
Journal:  Clin Immunol       Date:  2008-10-19       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.